INS and metabolic dysfunction-associated steatotic liver disease: Probiotics efficiently reduced NAFLD dysbiosis, fatty acid synthesis, inflammation, and metabolic endotoxemia in animal models [100,101,102], as well as liver aminotransferases, serum pro-inflammatory cytokine levels, total cholesterol and triglycerides, insulin sensitivity, HOMA-IR, and BMI in human interventions (Table 1).